Xenon Pharmaceuticals INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Xenon Pharmaceuticals Inc. has announced its annual meeting of shareholders will be held virtually on June 2, 2026, to vote on key corporate matters including director elections and equity incentive plans.
NASDAQ
Xenon Pharmaceuticals will hold its annual shareholder meeting virtually on June 4, 2025, to discuss financial statements, elect directors, approve executive compensation, and appoint auditors.
NASDAQ
Xenon Pharmaceuticals will hold its annual shareholder meeting virtually on June 4, 2025, to discuss financial statements, elect directors, and vote on executive compensation and auditor appointment.
NASDAQ
Xenon Pharmaceuticals is asking shareholders to approve amendments to its 2014 Equity Incentive Plan, including increasing the number of issuable shares by 5,200,000, at the upcoming annual meeting.